Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 2, 2012, Pages 293-299

  Tsantes, Argirios ^a   Tsangaris, Iraklis ^a   Kopterides, Petros ^a   Nikolopoulos, Georgios ^b   Kalamara, Eleni ^a   Antonakos, Georgios ^a   Kapsimali, Violetta ^c   Gialeraki, Argiri ^a   Dimopoulou, Ioanna ^a   Orfanos, Stylianos ^a   Dima, Kleanthi ^a   Travlou, Anthi ^a   Armaganidis, Apostolos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Hellenic Center for Diseases Control and Prevention   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

angiotensin converting enzyme; critical illness; I D polymorphism; sepsis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PREDNISOLONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CAUCASIAN; CLINICAL ASSESSMENT; COMORBIDITY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EPIDEMIOLOGICAL DATA; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HEART FAILURE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; STEROID THERAPY;

CRITICAL ILLNESS; FEMALE; GENE DELETION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEPSIS;

EID: 84860500587     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.752     Document Type: Article

References (30)

1. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14. (Pubitemid 29063218)
2. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000; 28:232-5. (Pubitemid 30091059)
3. Levi M, Keller TT, van Gorp E, ten Cate H. Infection and inflammation and the coagulation system. Cardiovasc Res 2003; 60:26-39. (Pubitemid 38373473)
4. Maniatis NA, Kotanidou A, Catravas JD, Orfanos SE. Endothelial pathomechanisms in acute lung injury. Vascul Pharmacol 2008; 49:119-33.
5. Constantinescu CS, Goodman DB, Ventura ES. Captopril and lisinopril suppress production of interleukin-12 in human peripheral blood mononuclear cells. Immunol Lett 1998;62: 25-31. (Pubitemid 28277393)
6. Harding D, Baines PB, Brull D, Vassiliou V, Ellis I, Hart A, et al. Severity of meningococcal disease in children and the angio-tensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002;165:1103-6. (Pubitemid 34415818)
7. Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hyper 1994;12(Suppl 4):S3-10.
8. Rigat B, Hubert C, Alhen-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion-deletion polymorphism in the angiotensin-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6. (Pubitemid 20370444)
9. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
10. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, et al. Angiotensin-converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646-50. (Pubitemid 34971844)
11. Pera J, Korostynski M, Krzyszkowski T, Czopek J, Slowik A, Dziedzic T, et al. Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflamma-tion? Stroke 2010;41:224-31.
12. Villar J, Flores C, Perez-Mendez L, Maca-Meyer N, Espinosa E, Blanco J, et al. Angiotensin-converting enzyme insertion/deletion polymorphism polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008;34:488-95. (Pubitemid 351623027)
13. Adamzik M, Frey U, Sixt S, Knemeyer L, Beiderlinden M, Peters J, et al. ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J 2007;29:482-8. (Pubitemid 46372094)
14. Casey L, Krieger B, Kohler J, Rice C, Oparil S, Szidon P. Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report. Crit Care Med 1981;9:651-4.
15. Suffredini AE, Chanock SJ. Genetic variation and the assessment of risk in septic patients. Intensive Care Med 2006;32:1679-80. (Pubitemid 44607349)
16. van de Garde EM, Endeman H, Deneer VH, Biesma DH, Ruven HJ, van Velzen-Blad H, et al. Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia. Clin Chem Lab Med 2007;45:1326-31. (Pubitemid 47557063)
17. Meijvis SC, Cornips MC, Endeman H, Ruven HJ, Danser AH, Biesma DH, et al. Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia. Clin Chem Lab Med 2011;49:1525-32.
18. Tsantes A, Tsangaris I, Nikolopoulos G, Bagos P, Kopterides P, Antonakos G, et al. The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis. Minerva Anestesiol 2010;76:787-94.
19. Tsantes AE, Tsangaris I, Bonovas S, Kopterides P, Rapti E, Dimopoulou I, et al. The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients. Blood Coagul Fibrinolysis 2010;21:175-81.
20. Levy MM, Fink M, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6. (Pubitemid 36444440)
21. Han Y, Runge MS, Brasier AR. Angiotensin II induces inter-leukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κ B transcription factors. Circ Res 1999;84:695-703. (Pubitemid 29157337)
22. von Depka M, Czwalinna A, Wermes C, Eisert R, Scharrer I, Ganser A, et al. The deletion polymorphism in the angio-tensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003;89: 847-52. (Pubitemid 36603428)
23. Kim DK, Kim JW, Kim S, Gwon HC, Ryu JC, Huh JE, et al. Polymorphism of angiotensin-converting enzyme gene is associated with circulating levels of plasminogen activator inhib-itor-1. Arterioscler Thromb Vasc Biol 1997;17:3242-7. (Pubitemid 28016084)
24. Brugts JJ, Den Uil C. ACE insertion/deletion polymorphism in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008;34:1733.
25. Al'tshuler BI, Poitman AP, Fedorova TA, Novozhenov VG, Belkov SA, Gordeev MN, et al. Change in activity of angio-tensin-converting enzyme in pneumonia and chronic obstructive lung diseases. Ter Arkh 2003;75:36-40. (Pubitemid 41295227)
26. Doerschug KC, Delsing AS, Schmidt GA, Ashare A. Renin angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care 2010;14:R24.
27. Brecher AS, Thevananther S, Wilson S. Observation of high and low molecular weight inhibitors of angiotensin-converting enzyme in rat lung. Arch Int Pharmacodyn Ther 1996;331:301-12. (Pubitemid 27026457)
28. Cox R, Bouzekri N, Martin S, Southam L, Hugill A, Golamaully M, et al. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 2002;11:2969-77.
29. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JCL. ACE polymorphisms. Circ Res 2006;98:1123-33. (Pubitemid 43948098)
30. Odawara M, Matsunuma A, Yamashita K. Mistyping frequency of the angiotensin-converting enzyme gene polymorphism and an improved method for its avoidance. Human Genet 1997; 100:163-6. (Pubitemid 27338784)